Trials / Not Yet Recruiting
Not Yet RecruitingNCT06803173
Pelvic Floor Muscle Activity in Primary Dysmenorrhea
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 77 (estimated)
- Sponsor
- Cairo University · Academic / Other
- Sex
- Female
- Age
- 19 Years – 24 Years
- Healthy volunteers
- Not accepted
Summary
This study will be conducted to assess the pelvic floor muscle (PFM) activity in primary dysmenorrhea (PD).
Detailed description
Dysmenorrhea, marked by painful menstrual cramps, often involves increased PFM tension, spasms, and inflammation, affecting females' quality of life and productivity. The traditional focus has been on investigating the abdominal region in women with PD. However, this new perspective considers that the hormonal changes experienced during the menstrual cycle in PD patients may lead to a heightened sensitivity of the PFM, not just the abdominal area. This suggests that the pain associated with PD may have a more widespread impact on the pelvic region rather than being localized to the abdomen. Pelvic floor myofascial trigger points (MTrPs) may also exacerbate menstrual pain through the neural pathway. There is a critical gap in the literature regarding the nature of the association between dysmenorrhea and PFM activity in this population. Yet, it is unknown whether the pain is a cause or result of increased PFM tone, and the nature of the association between menstrual pain and PFM tone in women with PD is also unknown. So, this study utilizes transabdominal ultrasound (TAU) to examine PFM activity in PD, aiming to clarify how PFM activity contributes to menstrual pain. Understanding these dynamics could lead to preventive strategies and educational efforts highlighting the role of pelvic floor interventions in managing dysmenorrhea, potentially improving treatment methods and overall women's health management.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | No intervention | No intervention |
Timeline
- Start date
- 2025-02-01
- Primary completion
- 2025-04-01
- Completion
- 2025-04-15
- First posted
- 2025-01-31
- Last updated
- 2025-01-31
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT06803173. Inclusion in this directory is not an endorsement.